<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clinical, cytomorphologic, and cytogenetic investigations were carried out in a series of 76 secondary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and ANLL </plain></SENT>
<SENT sid="1" pm="."><plain>Chromosome abnormalities were more frequent in patients with a history of <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> or <z:e sem="disease" ids="C0024419" disease_type="Neoplastic Process" abbrv="">macroglobulinemia</z:e> (92%) and <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> (82%) than in patients with previous <z:hpo ids='HP_0003002'>breast cancer</z:hpo> (40%) </plain></SENT>
<SENT sid="2" pm="."><plain>The secondary <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> were mostly a trilineage <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone marrow disorder</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The most commonly found cytogenetic anomaly was <z:mp ids='MP_0004026'>monosomy</z:mp> 7, followed by total or partial loss of chromosome 5 </plain></SENT>
<SENT sid="4" pm="."><plain>In addition six other chromosomes, i.e., chromosome 3, 8, 9, 12, 17, and 21 seemed to be consistently involved in the pathogenetic mechanisms of secondary <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>